Introduction
. In loss-of-function mutants for components of the PAR-3-PAR-6-aPKC complex, the cell fate determinants and their adapter proteins are mislocalized to the whole NB cortex and often fail to segregate correctly into the budding ganglion mother cell (GMC) (Schober et al., 1999; Wodarz et al., 1999; Petronczki and Knoblich, 2001; Rolls et al., 2003) .
The PAR-3-PAR-6-aPKC complex also functions during the specification and polarization of the oocyte. In null mutants of baz, par-6 and aPKC, an oocyte is initially specified, but the oocyte fate is not maintained in most egg chambers, resulting in the formation of 16 nurse cells and no oocyte (Cox et al., 2001; Huynh et al., 2001) . At stages 9-10 of oogenesis, Baz and aPKC are required to localize PAR-1 and Staufen to the posterior oocyte cortex (Vaccari and Ephrussi, 2002; Benton and St Johnston, 2003; Tian and Deng, 2008) .
How does the PAR-3-PAR-6-aPKC complex control cell polarity in these different cell types? According to genetic and biochemical data, mostly from Drosophila and mammalian tissue culture cells, Baz/PAR-3 is likely to function as a molecular scaffold that is required for the correct subcellular localization of the other components of the complex (Izumi et al., 1998; Schober et al., 1999; Wodarz et al., 1999; Joberty et al., 2000; Lin et al., 2000; Wodarz et al., 2000; Petronczki and Knoblich, 2001) . PAR-6 functions as a molecular linker between cdc42 and aPKC and modulates the kinase activity of aPKC (Joberty et al., 2000; Johansson et al., 2000; Lin et al., 2000; Yamanaka et al., 2001; Peterson et al., 2004) . The main active component of the complex is thought to be aPKC, which regulates the activities of other proteins functioning downstream in the cell polarity pathway by phosphorylation. Among the reported phosphorylation targets of aPKC that are involved in the regulation of cell polarity are Baz/PAR-3 (Nagai-Tamai et al., 2002) , the transmembrane protein Crumbs (Crb) (Sotillos et al., 2004) , Lethal giant larvae (Lgl) (Betschinger et al., 2003; Plant et al., 2003; Yamanaka et al., 2003) , PAR-1 (Hurov et al., 2004; Kusakabe and Nishida, 2004; Suzuki et al., 2004) and Numb (Smith et al., 2007; Wirtz-Peitz et al., 2008) .
Strong evidence for the importance of the kinase activity of aPKC for its function has been obtained both by overexpression of dominant negative and of constitutively active versions of aPKC in Drosophila (Betschinger et al., 2003; Sotillos et al., 2004; Lee et al., 2006a) and in mammalian tissue culture cells Hurov et al., 2004; Smith et al., 2007) . These studies have provided important insight into the function of aPKC in different contexts. However, these approaches relied on overexpression or ectopic expression of the respective modified forms of aPKC and do not necessarily reflect the requirement for the kinase activity of the endogenous protein expressed at physiological levels.
Here we present the molecular and phenotypic analysis of four new mutant alleles of aPKC in Drosophila that change single highly conserved amino acid residues. We show that these mutant forms of aPKC either fail to bind PAR-6 or lack kinase activity. Compared with the null allele aPKC k06403 used in all studies on Drosophila aPKC so far (Wodarz et al., 2000; Cox et al., 2001; Rolls et al., 2003; Harris and Peifer, 2007) , the mutant phenotypes of the new alleles show pronounced tissue specificity with strong defects in some tissues and phenotypes indistinguishable from wild type in others. We propose that the functional requirement for aPKC is tissue specific and that both the binding to PAR-6 and the kinase activity of aPKC are only required for a subset of its functions.
Results

Isolation of four hypomorphic alleles of aPKC
In a genetic screen for EMS-induced mutations in maternally expressed genes that affect the patterning and integrity of the first instar larval epidermis, we isolated four mutations that showed cuticle phenotypes indicative of the loss of epithelial integrity reminiscent of mutations in the crumbs gene ( Fig. 1) (Tepass et al., 1990; Luschnig et al., 2004) . All four alleles were viable but female sterile in transheterozygous combinations with each other and with the aPKC k06403 mutation (Table 1) (Luschnig et al., 2004) . aPKC k06403 has been classified as null allele because it is homozygous lethal and because no detectable protein is made in cells that are homozygous for this mutation (Wodarz et al., 2000; Rolls et al., 2003) . Three of the four new aPKC alleles were homozygous viable, with the exception of aPKC psu417 , which is lethal at the second larval instar stage (Table 1) (Luschnig et al., 2004) . In animals homozygous mutant for any of the four new aPKC alleles full-length mutant proteins were detectable by western blot (data not shown). These results together with the phenotypic and molecular analysis presented below show that all four mutations are hypomorphic alleles of aPKC that retain partial functionality.
Journal of Cell Science 122 (20) Fig. 1 . aPKC mutant embryos derived from germ-line clones show loss of epithelial integrity in the epidermis. (A)Cuticle preparation of a wild-type embryo showing a contiguous cuticle with ventral denticle bands (arrowheads) and the head skeleton (arrow). (B-F)Cuticles of aPKC mutant embryos derived from germ-line clones show only crumbs of cuticle (B,C,F) or rudimentary patches of contiguous cuticle (D,E; between white lines), indicative of a breakdown of epithelial tissue structure. The phenotypes of the aPKC psu69 (B) and aPKC psu141 (C) class I alleles are indistinguishable from the null allele aPKC k06403 (F), whereas the phenotypes of the aPKC psu265 (D) and aPKC psu417 (E) class II alleles are much milder. Arrowheads in D point to rudimentary denticle bands. The cuticle phenotype of par-6 226 null mutant embryos derived from germ-line clones (G) resembles the aPKC null mutant phenotype. Anterior is to the left in all panels. Scale bar:100m.
Embryos derived from germ-line clones of the hypomorphic aPKC alleles loose apical-basal polarity in the embryonic ectoderm Embryos homozygous mutant for the null allele aPKC k06403 develop normally because of maternally provided aPKC and die during larval stages when the maternal pool of aPKC is exhausted (Rolls et al., 2003) . To analyze the phenotype of the new aPKC alleles during development of embryonic ectodermal epithelia in the absence of maternally provided wild-type aPKC, we generated germ-line clones of all four hypomorphic aPKC alleles, of the null allele aPKC k06403 , and of the null allele par-6 226 . Cuticle preparations of germ-line clone embryos from two hypomorphic aPKC alleles that we refer to as class I alleles (aPKC psu69 and aPKC psu141 ) showed only scattered crumbs of cuticle ( Fig. 1B,C) , very similar to the 
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Fig. 2.
Apical-basal polarity of the ectodermal epithelium is disrupted in aPKC and par-6 mutant embryos derived from germ-line clones. The ectodermal epithelium of wild-type and mutant embryos at stage 7 was stained for aPKC (A-E), PAR-6 (F-J), Baz (K-O), Nrt, Crb and Dlg (P-TЈ). Scale bars: 10m (A-O); 10m (P-T). (U)Ultrastructure of the wildtype embryonic epidermis at stage 11. There is a contiguous electron dense ZA (UЈ, red arrows) in the apical portion of the lateral membrane. By contrast, aPKC psu141 mutant embryos at the same stage do not possess a contiguous ZA (V,VЈ). Instead, spot adherens junctions are found in ectopic positions along the lateral membrane (VЉ, arrow). Scale bars: 0.5m (U-VЉ). In all images apical is to the top. cuticle phenotype of aPKC k06403 (Fig. 1F ), par-6 ( Fig. 1G ), crb and sdt mutants, which show complete disintegration of the embryonic epidermis (Tepass et al., 1990; Wodarz et al., 1995; Grawe et al., 1996; Bachmann et al., 2001; Hong et al., 2001; Petronczki and Knoblich, 2001; Hutterer et al., 2004; Harris and Peifer, 2005) . The hypomorphic class II alleles (aPKC psu265 and aPKC psu417 ) showed a weaker phenotype with contiguous patches of cuticle, including remnants of denticle belts (Fig. 1D,E) .
In order to understand the development of this terminal phenotype in the aPKC germ-line clone embryos, we analyzed, by confocal microscopy, the subcellular localization of the mutant aPKC proteins and of several other proteins with a polarized localization in epithelia. Wild-type aPKC was localized to spots at the most apical region of the lateral plasma membrane of the ectodermal epithelium from cellularization onwards ( Fig. 2A ) (Wodarz et al., 2000; Harris and Peifer, 2005) . By contrast, in embryos derived from germ-line clones, both mutant aPKC proteins encoded by the class I alleles were not localized to the cortex at all and instead showed a diffuse, cytoplasmic localization ( Fig. 2B ). aPKC proteins encoded by the class II alleles were localized similarly to wild-type aPKC at gastrulation ( Fig. 2C ) but became scattered along the lateral cortex later in development (data not shown). aPKC was diffusely localized in par-6 226 germ-line clone embryos lacking maternal and zygotic PAR-6, demonstrating that PAR-6 is required for cortical localization of aPKC ( Fig. 2E) .
In wild type, the subcellular localization of PAR-6 ( Fig. 2F ) is essentially identical to that of aPKC. PAR-6 was diffuse in the cytoplasm in embryos mutant for each of the class I aPKC alleles ( Fig. 2G ) and in embryos mutant for the null allele aPKC k06403 (Fig.  2I ). In embryos mutant for the class II aPKC alleles, PAR-6 was localized to the apical cortex at gastrulation ( Fig. 2H ), as it was in the wild type.
The localization of Baz to the apical region of the lateral plasma membrane of the blastoderm epithelium at cellularization was unaffected by loss of aPKC function, both in germ-line clones of the null allele aPKC k06403 and in germ-line clones of all four hypomorphic alleles (data not shown) (Harris and Peifer, 2007) . At this stage, Baz was also localized normally in par-6 226 mutant embryos (data not shown). During early gastrulation, the apicolateral localization of Baz was initially only slightly altered and Baz frequently formed larger particles in embryos mutant for all five aPKC alleles and in par-6 226 mutant embryos ( Fig. 2K-O) . During germ-band extension the apicolateral localization of Baz was gradually lost in embryos mutant for class I aPKC alleles, in embryos mutant for the null allele aPKC k06403 , and in par-6 226 mutant embryos (supplementary material Fig. S1 ) (Harris and Peifer, 2005; Harris and Peifer, 2007) . In class II aPKC mutants, the localization of Baz at the corresponding developmental stages was heterogeneous, with areas showing almost normal localization and adjacent areas where Baz was completely mislocalized (supplementary material Fig. S1 ).
We also analyzed the subcellular localization of other proteins that show a polarized distribution in epithelia in aPKC mutant embryos. In wild-type epithelia, the transmembrane protein Crb localized to the subapical region (SAR) and to the free apical surface (Fig. 2P ). Just below the SAR, DE-Cadherin (also known as Shotgun) localized to the zonula adherens (ZA; data not shown), and the transmembrane protein Neurotactin (Nrt) localized to the whole basolateral membrane (Fig. 2P ). The cortical protein Discs large (Dlg) was present along the whole basolateral membrane and was enriched at the membrane immediately basal to the ZA, at the position of the future septate junction (Fig. 2PЈ ). In embryos mutant for class I aPKC alleles and in aPKC k06403 null mutant embryos, all four proteins were mislocalized ( Fig. 2Q ,S). Crb was completely lost from the SAR and from the apical membrane and was instead found in scattered vesicles in the cytoplasm (Fig. 2Q,S) . DE-Cadherin, Nrt and Dlg were still present at the membrane but were not restricted to their normal position. Instead, all three proteins were detectable all around the cells, including the free apical membrane, pointing to a complete loss of plasma membrane polarity in the mutant embryos ( Fig. 2Q,S) . Moreover, the epithelial cells had lost their columnar, monolayered organization, rounded up and lost contact to each other ( Fig. 2Q,S) . par-6 226 mutant embryos showed the same phenotype with respect to the mislocalization of Crb, Nrt and Dlg (Fig. 2T ). The mislocalization of the four polarity markers was less severe in class II aPKC mutant embryos, where patches of normal Crb localization to the apical membrane were still present ( Fig. 2R ).
Together, these results show that hypomorphic aPKC class I mutants show phenotypes similar to the aPKC and PAR-6 null alleles with respect to cuticle phenotype and the subcellular localization of several polarity markers, whereas aPKC class II alleles produced weaker phenotypes in every aspect that we analyzed.
Ultrastructural examination of aPKC psu141 (class I) mutant embryos revealed that the neuroectodermal epithelium did not possess a contiguous ZA, consistent with the observed mislocalization of DE-cadherin ( Fig. 2V ). Instead, spot adherens junctions were found in ectopic positions along the lateral plasma membrane (Fig. 2V ).
Mutations in crb, sdt and several other genes that result in loss of epithelial cell polarity and failure to form a ZA cause massive apoptosis in epithelial cells from mid-embryogenesis onwards (Tepass and Knust, 1993; Grawe et al., 1996) . This was also the case for the four hypomorphic aPKC alleles, as detected by TUNEL and staining for the activated caspase Drice (supplementary material Fig. S2B ). Apoptotic cells frequently were not internalized and engulfed by macrophages, as in wild type (supplementary material Fig. S2C ) but remained on the surface of the embryo (supplementary material Fig. S2D ).
aPKC is required for the correct localization of PAR-6 and Miranda in embryonic neuroblasts
In wild-type NBs at metaphase, aPKC, PAR-6 and Baz colocalize in an apical cortical crescent whereas Miranda forms a basal cortical crescent ( Fig. 3A,H,O) . In order to study the requirement for aPKC during the asymmetric division of embryonic neuroblasts, we analyzed germ-line clone embryos by confocal microscopy. The mutant aPKC proteins encoded by the class I alleles were localized diffusely in the cytoplasm and never formed apical crescents ( Table S1 ). Complete mislocalization of aPKC to the cytoplasm was also observed in par-6 226 mutant embryos ( Fig. 3G ). By contrast, the mutant aPKC proteins encoded by the class II alleles localized to the apical cortex of neuroblasts in 78% and 53% of cases, respectively ( Fig. 3D ,E; supplementary material Table S1 ).
PAR-6 never formed apical crescents in NBs of aPKC k06403 null mutant embryos ( Fig. 3M ) and in only 29% of germ-line clone aPKC psu69 mutant embryos (Fig. 3I ). In embryos mutant for the other three hypomorphic alleles the apical localization of PAR-6 in NBs was also reduced, but not to the same extent as in the null and aPKC psu69 mutants ( Fig. 3J -L; supplementary material Table S2 ). Table S3 ). Only in aPKC k06403 null mutant embryos was apical localization of Baz reduced to 30% ( Fig. 3T ; supplementary material Table S3 ). In par-6 226 mutant embryos, Baz was still localized to the apical cortex of NBs in 67% of the embryos (Fig. 3U ).
The PAR-3-PAR-6-aPKC complex is required for the basal localization of cell fate determinants in metaphase NBs (Schober et al., 1999; Wodarz et al., 1999; Petronczki and Knoblich, 2001; Rolls et al., 2003) . In NBs of aPKC k06403 null mutant embryos the adapter protein Miranda never localized as a basal crescent as in wild type but instead was found all around the cortex, at the apical cortex or diffuse in the cytoplasm ( Fig. 3T ; supplementary material Table S4 ). The four hypomorphic aPKC alleles resulted in Mira being either localized to the basal cortex or to the whole cortex to different degrees, with the weakest defects seen in the aPKC psu265 class II mutants and the strongest defects seen in the aPKC psu417 class II mutants (Fig. 3P-S; supplementary material Table S4 ).
We noted that the orientation of the metaphase plate and of the asymmetric crescent of Baz was abnormal in a fraction of aPKC mutant NBs in embryos derived from germ-line clones (Fig. 3S,T) . The quantification of these defects is shown in supplementary material Fig. S3 .
Female sterility in animals mutant for the hypomorphic aPKC alleles
Females homozygous for any of the three viable hypomorphic alleles were sterile and their ovaries lost the monolayered organization of the follicle epithelium ( Fig. 4B ). In follicle cells that were in contact with germ-line cells PAR-6 was apically localized (Fig. 4B ), similar to wild-type follicle cells ( Fig. 4A ). By contrast, follicle cells that did not touch germ-line cells because of the multilayering of the epithelium showed diffuse cortical staining for PAR-6 ( Fig. 4B ). In many mutant egg chambers, the follicle epithelium was discontinuous and failed to ensheath the germ-line cells (Fig. 4B ). In all transheterozygous combinations of the hypomorphic aPKC alleles the females were sterile and showed the same defects as observed in homozygous mutant females.
Follicle cell polarity is normal in clones of cells homozygous for hypomorphic aPKC alleles
To analyze the effect of the mutations in the new aPKC alleles on the integrity and polarity of the follicle epithelium, we generated follicle cell clones. Although follicle cell clones of the null allele aPKC k06403 showed a complete loss of apical-basal polarity and extensive multilayering of the mutant cells ( Fig. 4E ) (Cox et al., 2001; Abdelilah-Seyfried et al., 2003) , clones of each of the new aPKC alleles showed only subtle defects, if any ( Fig. 4C,D) . In general, follicle cells mutant for any of the hypomorphic aPKC alleles showed normal apical-basal polarity with respect to the subcellular localization of the mutant aPKC itself and of the apical markers Baz, PAR-6 and Crb ( Fig. 4C ,D; and data not shown). In rare cases we observed egg chambers with follicle cell clones that had gaps in the follicle epithelium ( Fig. 4D) .
Oocyte determination and polarity are unaffected in germ-line clones of the hypomorphic aPKC alleles To investigate the functionality of the proteins encoded by the four new aPKC alleles in germ-line cells of the ovary without compromising aPKC function in the follicle epithelium, we generated clones of homozygous mutant germ-line cells by FLP-FRT-mediated mitotic recombination. Oocyte determination occured normally in the vast majority of egg chambers with germline clones (93.7%, n111), as demonstrated by expression of the oocyte-specific Orb protein in only one of the 16 germ-line cells after stage 4 of oogenesis ( Fig. 4F,G) . By contrast, in only 28% (n64) of germ-line clones of the null allele aPKC k06403 , was an oocyte specified ( Fig. 4H ), consistent with published data (Cox et al., 2001) . The germ-line clone oocytes mutant for any of the four new alleles did not show any obvious defects in the localization of Staufen, Gurken (Fig. 4J ,K; 100% normal localization of both proteins, n49) and Vasa (data not shown) at stage 9-10, indicating that the anterior-posterior polarization of the oocyte was unaffected. The localization of Staufen and Gurken in aPKC k06403 mutant Fig. 3 . Neuroblast polarity in aPKC and par-6 mutant embryos derived from germ-line clones. Wild-type and mutant NBs at metaphase were stained for aPKC (red; A-G), PAR-6 (red; H-N), Baz (red) and Mira (blue; O-UЉ). DNA was stained with YOYO-1 (green). Note that spindle orientation deduced from the orientation of the metaphase plate and the position of the Baz crescent was occasionally abnormal (S,T). Scale bar: 5m. In all panels, apical is up. oocytes at stage 9-10 was also normal in most cases (95% normal localization, n20; data not shown), suggesting that aPKC has only a minor function in the control of anterior-posterior oocyte polarity in late oogenesis.
The four hypomorphic aPKC alleles encode mutant proteins with changes in single, highly conserved amino acid residues Sequencing of genomic DNA from the aPKC locus of the mutant chromosomes revealed the presence of point mutations leading to single amino acid changes in all four alleles (Fig. 5A ). All four mutations alter amino acid residues that are identical in the aPKCs of all species analyzed so far, indicating that these residues are functionally important (supplementary material Fig. S4 ).
The position of the altered amino acids resulting from the four novel alleles allowed predictions regarding the functions that may be affected by the mutations. The mutation in aPKC psu69 changes cysteine 122 to tyrosine ( Fig. 5A ; supplementary material Fig. S4 ). Since this residue is positioned close to the PB1 domain that is required for binding of aPKC to PAR-6 (Noda et al., 2003; Wilson et al., 2003; Hirano et al., 2005) , we tested whether the binding to PAR-6 was affected in this mutant protein. To that aim, we expressed N-terminally GFP-tagged versions of full-length wildtype aPKC and the four mutant versions of aPKC in Drosophila S2 cells and checked for binding to the endogenous PAR-6 by coimmunoprecipitation experiments. Whereas GFP-wtaPKC, GFP-aPKC psu141 , GFP-aPKC psu265 and GFP-aPKC psu417 all bound endogenous PAR-6, the binding of GFP-aPKC psu69 to PAR-6 was completely abolished, irrespective of whether the anti-PAR-6 antibody or the anti-GFP antibody was used for coimmunoprecipitation ( Fig. 5B ). By contrast, both GFP-wtaPKC and all four mutant versions of GFP-aPKC bound equally well to Lgl and to Baz (data not shown), two additional known binding partners of aPKC (Wodarz et al., 2000; Betschinger et al., 2003) .
The mutation in aPKC psu141 changes phenylalanine 423 to isoleucine (Fig. 5A ). This residue is located within the activation loop of the kinase and lies right next to threonine 422, which is the predicted phosphorylation target of phosphatidylinositol dependent kinase 1 (PDK1; supplementary material Fig. S4 ) (Chou et al., 1998; Le Good et al., 1998) . Since phosphorylation of T422 is sequence specific, we predicted that mutation of F423 prevents phosphorylation of T422 by PDK1 and thus blocks activation of aPKC. A phosphospecific antibody is available that distinguishes aPKC phosphorylated at T422 from the unphosphorylated form. In S2 cells transfected with wild-type GFP-aPKC, the GFP-tagged protein was recognized by the phosphospecific antibody, in contrast to the mutant GFP-aPKC psu141 (Fig. 5C ). In extracts of heads of flies homozygous for aPKC psu141 , we could not detect any endogenous mutant aPKC protein with the antibody specific for aPKC phosphorylated at T422 (Fig. 5C ).
The mutation in aPKC psu265 changes the conserved alanine residue A291 to valine (Fig. 5A ). A291 lies in the immediate vicinity of K293 (supplementary material Fig. S4 ), a lysine residue in the ATP binding pocket of the kinase domain that is essential for the kinase activity of all aPKC familiy members (Newton, 1995) . The mutation in aPKC psu417 changes the conserved glycine residue G347 in the kinase domain to an asparagine residue (Fig. 5A) . To test whether any of the four mutations described here affect the kinase activity of the mutant proteins, we performed in vitro kinase assays, and for comparison included the mutant protein GFP-aPKC K293A , which carrries a point mutation leading to the exchange of the active site lysine residue for alanine which renders it kinase-dead (Sotillos Journal of Cell Science 122 (20) Fig. 4 . aPKC mutant phenotypes in oogenesis. (A)In wild-type egg chambers, the follicular epithelium has a regular, monolayered structure and PAR-6 is localized to the apical cortex of the follicle cells. (B)Egg chambers of homozygous aPKC psu69 mutant females show both multilayering and large gaps (arrowheads) in the follicle epithelium. Note that PAR-6 is still localized apically in follicle cells that are in direct contact with the germ-line cells. Scale bar: 10m (A,B). (C-EЈ) The phenotype of the hypomorphic aPKC alleles in homozygous mutant follicle cell clones is much milder than that of the aPKC null allele. Follicle cell clones of aPKC psu417 (C,CЈ) and of aPKC psu69 (D,DЈ) show a normal monolayered tissue structure and correct localization of the mutant aPKC (red) and PAR-6 (blue) to the apical cortex. Occasionally, gaps are observed in the follicle epithelium of egg chambers carrying clones of aPKC mutant cells (D,DЈ,DЉ, arrowheads). In contrast to the hypomorphic aPKC alleles, follicle cell clones of the null allele aPKC k06403 (E,EЈ,EЉ) show multilayering of the epithelium and a complete loss of the apical localization of Bazooka (blue). Clones of homozygous mutant follicle cells are marked by the absence of GFP (green). Scale bar: 10m (C-EЉ). (F-H)Oocyte determination occurs normally in aPKC psu417 (F) and aPKC psu265 (G) germline clones, but not in the the null allele aPKC k06403 germ-line clone (H), which shows loss of the oocyte in most egg chambers. Oocytes are marked by staining for Orb (red) and homozygous mutant cells are marked by absence of GFP (green, arrows). Scale bar: 10m (F-H). (I-K)Anterior-posterior polarity of the oocyte is normal in aPKC psu69 and aPKC psu417 germ-line clones. In wildtype oocytes (I), Gurken (red) is localized to the anterior dorsal cortex and Staufen (blue) to the posterior cortex of the oocyte. The localization of Gurken and Staufen in germ-line clones of aPKC psu69 (J) and aPKC psu417 (K) is indistinguishable from that in wild-type. Germ-line clones are marked by absence of GFP staining (insets) in nurse cells and oocytes. Scale bar: 50m (I-K). Anterior is to the left in all panels. et al., 2004) . The full-length wild-type GFP-aPKC fusion protein and the GFP-aPKC psu69 fusion protein showed comparable levels of kinase activity when tested for autophosphorylation or phosphorylation of a GST-Baz fusion protein containing the aPKC target site S980 in radioactive in vitro kinase assays (Fig. 5D ). By contrast, the mutant fusion proteins GFP-aPKC psu141 , GFP-aPKC psu265 and GFP-aPKC psu417 showed strongly reduced kinase activity in both assays with GFP-aPKC psu417 , being indistinguishable in its activity from the kinase-dead mutant GFP-aPKC K293A (Fig.  5D ). To further consolidate this finding, we performed in vitro kinase (B) The GFP-aPKC psu69 protein does not bind to PAR-6. S2 cells were transfected with wild-type GFP-aPKC and with the four mutant versions of GFP-aPKC. Untransfected S2 cells were used as negative control. The cell lysates were subjected to immunoprecipitation (IP) followed by western blotting (Blot) with the indicated antibodies. Preimmune serum (pre; for PAR-6 IPs) or anti--galactosidase antibodies (-Gal; for GFP IPs) were used as negative controls. (C)The mutant aPKC psu141 protein is not recognized by the phospho-specific antibody directed against the phosphorylated threonine residue T422. Lysates from S2 cells transfected with GFP-aPKC or with GFPaPKC psu141 were subjected to western blotting with either an antibody that recognizes aPKC irrespective of its phosphorylation state (aPKC) or with an antibody that specifically recognizes aPKC phosphorylated at T422 (aPKCpT422). A T422 phospho-specific band corresponding to GFPaPKC, but not to GFPaPKC psu141 was detected. Untransfected S2 cells were used as negative controls. The endogenous aPKC band served as loading control. This observation was confirmed in western blots of adult head extracts of wild-type and aPKC psu141 homozygous mutant flies (right). (D)Three of the four mutant aPKC proteins show strongly reduced kinase activity. In vitro kinase assays using [-32 P]ATP were performed on anti-GFP immunoprecipitates of lysates of S2 cells transfected with either wild-type GFP-aPKC, with any of the four mutant GFP-aPKC versions and with GFP-tagged kinase-dead aPKC (GFP-aPKC K293A ). Untransfected cells and cells transfected with wild-type GFP-aPKC but immunoprecipitated with anti-HA antibody were used as negative controls. Both autophosphorylation of GFP-aPKC and phosphorylation of a GST-Baz fusion protein containing the aPKC target site S980 were measured by autoradiography. One representative autoradiogram is shown. The quantitative analysis of four independent in vitro kinase assays is shown in the bar diagrams below the autoradiographs. Values are percentage phosphorylation relative to that of the wild-type GFP-aPKC protein. The input for the kinase assay (top) is shown at the bottom. (E)Three of the four mutant aPKC proteins are kinase-dead with respect to phosphorylation of S980 of Baz. In vitro kinase assays were performed with non-radioactive ATP as phosphate donor and phosphorylation of the GST-Baz fusion protein was detected in western blots using a phospho-specific antibody against S980 of Baz. The immunoprecipitated GFP-aPKC from the same experiment was also detected by western blotting. Quantification of the blots with the phospho-specific Baz antibody from four independent experiments and the GST-Baz input corresponding to the kinase assay (top) are shown at the bottom. assays using a phosphospecific antibody directed against pS980 of Baz (Krahn et al., 2009) , which is homologous to pS827 of mammalian PAR-3 (Nagai-Tamai et al., 2002) . This highly substrate-specific assay confirmed the findings from the radioactive kinase assays and showed that GFP-aPKC psu141 and GFP-aPKC psu265 also have little if any kinase activity in vitro (Fig. 5E ).
Effects of the mutations on ATP binding and protein folding
To test if the observed loss of kinase function for the point mutations A291V (aPKC psu265 ), G347N (aPKC psu417 ) and F423I (aPKC psu141 ) is either due to changed substrate affinity or, alternatively, to a possible destabilization of the folded state, free energy calculations based on extended molecular dynamics simulations were carried out. Since the crystal structure of Drosophila aPKC has not been solved, we used the published structure of human PKC (Messerschmidt et al., 2005) (Fig. 6 ) as the basis for our calculations, which is 67% identical to Drosophila aPKC. All three residues affected by the mutations in Drosophila aPKC are identical to the homologous residues in human PKC (supplementary material Fig. S4 ). Moreover, the regions harboring the three mutations are highly conserved in both proteins, such that the relevant free energy double differences are expected to be unaffected by distant sequence differences. A similar argument holds for the structural elements (Fig. 6A, blue) , which were not resolved in the crystal structure and, therefore, had to be modeled. Table 2 shows the relevant differences as well as the double differences G fold(3/5) and G bind . The latter express the change in folding free energy and ATP binding free energy, respectively, caused by the mutation. Our free energy calculations predict a 14 times lower ATP binding affinity for the A272V mutation (homologous to Drosophila A291V) as compared with the wild type, which provides a plausible explanation for the observed loss of function. The ATP binding affinity of the G328N mutation (homologous to Drosophila G347N), in contrast, is higher by a factor of 50 and, therefore, loss of function of that mutant probably has other causes. Because in this case the folding equilibrium constant is larger by four orders of magnitude, we suggest misfolding as the most likely alternative explanation. For the F404I mutant (homologous to Drosophila F423I), both the ATP binding affinity as well as the folding free energy are nearly unchanged, thus ruling out both of these possible explanations. Also, this residue is unlikely to affect the ATP binding affinity of aPKC because of the large distance between F404 and the ATP-binding pocket (Fig. 6A ).
Discussion
aPKC is often regarded as the main catalytically active component of the PAR-3-PAR-6-aPKC complex that controls cell polarity by phosphorylation of critical targets. In this model, the other two components of the complex, Baz/PAR-3 and PAR-6 serve mainly as scaffolding proteins that are responsible for the correct localization of aPKC and for regulating its catalytic activity (Wodarz, 2005; Suzuki and Ohno, 2006; Knoblich, 2008) . However, this concept has never been rigourosly tested because of the lack of mutations in aPKC that specifically compromise the binding of aPKC to PAR-6 or its kinase activity but leave the remainder of the protein intact. All genetic analyses performed in Drosophila so far relied on the aPKC k06403 null allele, which does not give rise to any detectable aPKC protein (Wodarz et al., 2000; Cox et al., 2001; Rolls et al., 2003) . Here we have analyzed four new alleles of aPKC carrying single base changes leading to the exchange of single highly conserved amino acid residues. The molecular and biochemical analysis of these alleles revealed that Journal of Cell Science 122 (20) Fig. 6 . Structure of human PKC and thermodynamic cycles. (A)Overall structure of human PKC with modeled structure elements (blue) and mutated residues (red). The enlarged view (right) compares the ATP binding pocket of the wild-type structure (green) with that of the A272V mutant (dark blue). (B)Thermodynamic cycles used in the free energy calculations described in the text. WT and Mut. refer to the wild-type and each of the considered mutant structures, respectively; the indices (f) and (u) refer to the folded and unfolded states, respectively. The color codings of the free energy double differences (G bind and G fold ) correspond to the respective mutated amino acids in A. G f denotes the free energy difference for the folded and ligand-free protein, G +ATP for the Mg 2+ -ATP bound complex, G u3 for the tripeptide, and G u5 for the pentapeptide. G bind G f -G +ATP denotes the ATP binding free energy difference between wild type and the respective mutant, G fold(3) between G f and G u3 , and G fold(5) between G f and G u5 . All energies are given in kJ/mol. either the binding to PAR-6 or the kinase activity of aPKC is abolished in the mutant proteins. Our free energy calculations of the three mutants lacking kinase activity suggest that in one mutant the binding of ATP is strongly compromised while in a second mutant protein misfolding is the most likely cause for the observed loss of function. Both the binding to PAR-6 and the kinase activity were thought to be essential for the correct localization and function of aPKC, according to the model discussed above. Nonetheless, all four alleles behave as hypomorphs by genetic criteria and with regard to the severity of the mutant phenotypes. Interestingly, the severity of the mutant phenotype differs dramatically between different tissues. All four hypomorphic alleles result in severe defects in the embryonic epidermis and in embryonic neuroblasts, while oocyte determination and the polarity of the follicle epithelium are largely unaffected.
The four hypomorphic alleles of aPKC result in strong mutant phenotypes in embryonic epithelia
Embryos derived from germ-line clones for any of the four hypomorphic aPKC alleles showed severe defects in ectodermal epithelia. Their cuticle phenotypes, in particular those of the class I alleles, were very similar to those of crb, sdt, baz and par-6 mutants, which have almost complete loss of apical-basal polarity and integrity of ectodermal epithelia (Tepass et al., 1990; Grawe et al., 1996; Müller and Wieschaus, 1996; Tepass, 1996; Bachmann et al., 2001; Hong et al., 2001; Petronczki and Knoblich, 2001) . This was confirmed at the ultrastructural level, since the defects in ZA formation in aPKC mutant embryos were very similar to those of crb, sdt and baz mutants (Grawe et al., 1996; Müller and Wieschaus, 1996; Tepass, 1996; Bachmann et al., 2001; Hong et al., 2001) . Consistent with these observations, Crb was not localized to the plasma membrane at all and instead was in cytoplasmic vesicles in class I aPKC mutant embryos. It is conceivable that the trafficking of Crb to the apical plasma membrane is dependent on direct phosphorylation by aPKC (Sotillos et al., 2004) . Alternatively, because Crb and its binding partner Sdt/PALS1 can directly bind to PAR-6 (Hurd et al., 2003; Lemmers et al., 2004; Wang et al., 2004; Kempkens et al., 2006) and aPKC and PAR-6 are mutually dependent on each other for their correct localization in the epidermis, the mislocalization of Crb in aPKC mutant embryos could also be caused by the mislocalization of PAR-6. It has recently been reported that Cdc42 and the PAR-3-PAR-6-aPKC complex are required to suppress apical endocytosis in tissues undergoing strong morphogenetic movements, such as the neurogenic ectoderm (Harris and Tepass, 2008) . Our finding that in aPKC mutant embryos Crb is in vesicles instead of being localized to the apical plasma membrane is fully consistent with this model. The severity of the mutant phenotypes in the epidermis differed considerably between class I and class II alleles. This difference cannot be accounted for by a difference in the kinase activity of the mutants, since both proteins encoded by the class II alleles and the protein encoded by the class I allele aPKC psu141 showed the same reduction in kinase activity, which was indistinguishable from the kinase-dead aPKC K293A protein. We therefore speculate that the difference may be caused by the effects of the mutations on the scaffolding function of aPKC. The protein encoded by the class I allele aPKC psu69 is unable to bind PAR-6 and thus cannot assemble a functional PAR-3-PAR-6-aPKC complex. Similarly, the protein encoded by the class I allele aPKC psu141 carries a mutation in the recognition sequence for PDK1 and thus may fail to bind PDK1. Moreover, the failure of the aPKC psu141 protein to be phosphorylated by PDK1 may prevent a conformational change that allows additional proteins to bind aPKC (Hirai and Chida, 2003) .
Quite surprisingly, the class II allele aPKC psu417 is the only one of the four hypomorphic aPKC alleles that is lethal in homozygosity. Since it is viable in combination with all other alleles, including the null allele aPKC k06403 , we believe that the lethality of this allele is caused by a second site hit and not by the loss of aPKC function.
Binding to PAR-6 and kinase activity of aPKC are dispensable for the function of aPKC in the follicle epithelium In the follicle epithelium, even in large clones of follicle cells mutant for any of the four hypomorphic alleles the localization of the mutant aPKC itself, PAR-6 and Baz was normal. Also, the mutant follicle cells were always organized in a monolayer. By contrast, follicle cell clones with the null allele aPKC k06403 showed severe defects. aPKC k06403 mutant cells completely lost polarity, failed to localize PAR-6 and Baz to the apical cortex and piled up on top of each other. Thus, although the presence of aPKC is essential, neither the binding between aPKC and PAR-6 nor the kinase activity of aPKC is required for normal development of the follicle epithelium during oogenesis.
All females homozygous mutant for any of the three viable aPKC alleles showed multilayering of the follicle epithelium, whereas follicle cell clones of the same alleles never showed this phenotype. Nonetheless, even in areas with multilayered tissue organization, follicle cells that were in contact with germ-line cells showed normal apical-basal polarity. Thus, we favor the idea that in ovaries of animals homozygous mutant for one of the hypomorphic aPKC alleles the simultaneous loss of aPKC function in germ-line cells and follicle cells may disturb the interaction between these cell types early during egg chamber formation, which could cause the multilayering of the follicle epithelium.
Why are the mutant phenotypes of the four hypomorphic aPKC alleles much stronger in the embryonic ectodermal epithelium than in the adult follicle epithelium? This is not the case for the null allele of aPKC, which causes an almost complete loss of cell polarity and tissue integrity in both tissues. The reason may lie in the different ways these two epithelia are formed. The polarity of the embryonic ectodermal epithelium is established at cellularization, when no basement membrane is present, and thus relies predominantly on apical cues, in particular the PAR-3-PAR-6-aPKC complex and the Crb-Sdt complex (Tepass et al., 1990; Wodarz et al., 1995; Müller and Wieschaus, 1996; Bachmann et al., 2001; Hong et al., 2001; Harris and Peifer, 2004) . By contrast, the establishment of polarity in the follicle epithelium relies predominantly on basal cues provided by the basement membrane and only later on apical and lateral cues provided by the contact with germ-line cells and adjacent epithelial cells (Tanentzapf et al., 2000; Schneider et al., 2006; Mirouse et al., 2009) .
aPKC function in embryonic neuroblasts
Regarding their subcellular localization in embryonic NBs, the mutant proteins encoded by the four hypomorphic aPKC alleles behaved as they do in the epidermis: the mutant proteins encoded by the class I alleles never formed apical crescents in NBs, whereas the proteins encoded by the class II alleles were localized to the apical cortex in the majority of NBs. Similarly, apical localization of PAR-6 was abolished in the majority of NBs mutant for class I aPKC alleles but was largely normal in class II mutant NBs. Vice versa, aPKC was completely mislocalized in NBs mutant for par-6. Thus, we conclude that aPKC and PAR-6 are codependent for their proper localization in NBs, but that the kinase activity of aPKC is not essential in this context.
In contrast to the mislocalization of aPKC and PAR-6 in the hypomorphic aPKC mutant NBs, the localization of Baz was normal in most cases. However, only 30% of NBs mutant for the null allele aPKC k06403 showed apical localization of Baz. This finding suggests that neither the binding between aPKC and PAR-6 nor the kinase activity of aPKC is required for the apical localization of Baz in NBs, as long as aPKC is available as a binding partner of Baz. Support for this interpretation comes from our finding that the mutant proteins encoded by all four hypomorphic aPKC alleles retain their ability to bind Baz. An earlier study reported that apical localization of Baz in larval NBs was independent of aPKC (Rolls et al., 2003) . This result could reflect a different requirement for aPKC function in embryonic and larval NBs. Alternatively, residual maternal aPKC protein still present in larval NBs could explain this apparent discrepancy.
The PAR-3-PAR-6-aPKC complex is required for the localization of cell fate determinants, including Prospero and Numb, to the basal NB cortex (Wodarz, 2005; Knoblich, 2008) . This function is mediated by the activity of aPKC which phosphorylates Lgl in the apical cortex and thus prevents its association with the cortical cytoskeleton (Betschinger et al., 2003; Plant et al., 2003; Yamanaka et al., 2003; Betschinger et al., 2005) . Cortical Lgl in turn is required for the cortical localization of the adapter protein Miranda, which recruits Prospero to the cortex. In embryos mutant for any of the four hypomorphic aPKC alleles Miranda was mislocalized in metaphase NBs, but not to the same extent and with the same penetrance as in embryos mutant for the null allele aPKC k06403 . These findings show that the kinase activity of aPKC is important but may not be absolutely essential for inactivation of Lgl.
The four hypomorphic alleles of aPKC are fully functional in oocyte determination
The hypomorphic nature of the four new aPKC alleles was very obvious during oogenesis. Germ-line clones of the null allele aPKC k06403 failed to form an oocyte in 72% of the cases analyzed. By contrast, oocyte determination failed in only 6% of germ-line clones for any of the four new alleles, demonstrating that neither the loss of the kinase activity of aPKC nor the inability of aPKC to bind PAR-6 affect oocyte determination.
There are controversial reports about the involvement of aPKC and its phosphorylation targets in polarization of the oocyte at stages 9 and 10. Two papers claim that neither Lgl nor Crb are important for germ-line development (Benton and St Johnston, 2003; Doerflinger et al., 2006) , but a recent paper reported that the localization of Staufen is abnormal in 47% of aPKC k06403 mutant oocytes at stages 9-10 and that these defects are most probably caused by the failure to phosphorylate Lgl (Tian and Deng, 2008) . In our experiments, Staufen and Gurken localized normally in all oocytes mutant for any of the four hypomorphic aPKC alleles and in the vast majority of aPKC k06403 mutant oocytes at stage 9-10, which would suggest that there is no central function for aPKC in polarization of the oocyte at later stages of oogenesis.
Conclusions
We have described the molecular and biochemical properties and the mutant phenotypes of four hypomorphic alleles of aPKC encoding proteins that either fail to bind to PAR-6 or lack kinase activity. The reduced function of these alleles causes severe defects in apical-basal polarity in embryonic epithelia and neuroblasts, whereas oocyte determination and polarity of the follicle epithelium are nearly unaffected. Together, these data point to fundamental differences in the functioning of aPKC in these different tissues and they furthermore show that some functions of aPKC are independent of its kinase activity and of its ability to bind PAR-6.
Materials and Methods
Fly stocks and genetics 2R-69-30, 2R-141-24, 2R-265-2 and 2R-417-13 alleles are derived from a mosaic screen for maternal effect embryonic lethal mutations that were induced on a chromosome carrying the P{FRT(w hs )}G13 (42B) FRT element (Luschnig et al., 2004) and were renamed aPKC psu69 , aPKC psu141 , aPKC psu265 and aPKC psu417 in this work after demonstrating that they are hypomorphic alleles of aPKC. Mutations in aPKC psu flies (Luschnig et al., 2004) were identified by sequencing of PCR fragments encompassing the whole coding region of aPKC from genomic DNA of homozygous mutant or heterozygous flies. We furthermore used the null allele aPKC k06403 (Wodarz et al., 2000; Rolls et al., 2003) recombined onto the P{FRT(w hs )}G13 (42B) chromosome and the null allele par-6 226 recombined onto the P{FRT(w hs )}9-2 (18E) chromosome. Df(2R)Jp1/CyO (Bloomington Drosophila Stock Center #3518) takes out the whole aPKC locus. For generation of germ-line clone embryos with the FLP-DFS technique, the appropriate ovo D1 stocks were used (Chou and Perrimon, 1992; Chou and Perrimon, 1996) . For generation of genetically marked germ-line clones and follicle cell clones, appropriate FRT stocks carrying transgenes encoding green fluorescent protein (GFP) under control of the ubiquitin promoter were used.
Generation of antibodies against PAR-6 and Miranda
Antibodies against PAR-6 and Miranda were raised by injection of the keyhole limpet hemocyanin (KLH)-conjugated peptides HHQQAASNASTIMASDVKDGVLHL (PAR-6) and CSPPQKQVLKARNI (Miranda) into guinea pigs (Eurogentec, Herstal, Belgium).
Immunohistochemistry, TUNEL assay, electron microscopy and cuticle preparations
Embryos and ovaries were fixed in 4% formaldehyde and phosphate buffer pH 7.4. The primary antibodies used were rabbit anti-PKCz C20 (Santa Cruz Biotechnology) 1:1000, rabbit anti-Baz (Wodarz et al., 1999) 1:1000, guinea-pig anti-PAR-6 1:1000, guinea-pig anti-Mira 1:1000, rabbit anti-Insc (Kraut and Campos-Ortega, 1996) 1:1000, mouse anti-Nrt BP106 (DSHB) 1:5, rat anti-DE-Cadherin, DCAD-2 (Uemura et al., 1996) (DSHB) 1:20, rat anti-Crb (U. Tepass) 1:500, rabbit anti-Dlg (Woods and Bryant, 1991) 1:1000, mouse anti-Grk 1D12 (DSHB), rabbit anti-Staufen (St Johnston et al., 1991) 1:500, mouse anti-Orb 4H8 (DSHB) 1:20, rat anti-Vasa (Tomancak et al., 1998) 1:5000, rabbit anti-active DRICE (Yoo et al., 2002) 1:5000. DNA was stained with YOYO-1 (Invitrogen). Secondary antibodies conjugated to Cy2, Cy3, Cy5 (Jackson Laboratories) and Alexa-Fluor-647 (Invitrogen) were used at 1:400. Images were taken on a Leica TCSNT confocal microscope or on a Zeiss LSM 510 Meta confocal microscope and processed using Adobe Photoshop. TUNEL assays, for detection of cell death in situ, were performed as described previously (Wang et al., 1999) . Transmission electron microscopy was performed as described previously (Tepass and Hartenstein, 1994) . Cuticle preparations were done as described previously (Wieschaus and Nüsslein-Volhard, 1986 ).
Western blots and immunoprecipitation
Methods were as described by Wodarz (Wodarz, 2008) . For western analysis, the antibodies used were rabbit anti-PKCz C20 (Santa Cruz Biotechnology) 1:2000, rabbit anti-phospho-PKCz T410 (Santa Cruz Biotechnology) 1:1000, rabbit anti-BazpS980 (Krahn et al., 2009 ) 1:100, rabbit anti-GST (Sigma #G7781) 1:1000, and guinea-pig anti-PAR-6 1:2000. For immunoprecipitations, 2 l of rabbit anti-GFP (Molecular Probes #A11122), 2 l of guinea pig anti-PAR-6, 2 l of the corresponding preimmune serum, 10 l of rabbit anti--galactosidase (MP Biomedicals #55976) or 2 l of rat anti-HA 3F10 (Roche) were added to cell lysate containing 500 g of total protein from S2 cells in TNT (1% Triton X-100, 150 mM NaCl, 50 mM Tris-HCl pH 7.5) supplemented with protease inhibitors. Immune complexes were harvested using protein A/G-conjugated agarose (Roche), washed three times in TNT and boiled in 2ϫ SDS sample buffer before SDS-PAGE and western blotting.
In vitro kinase assays
In vitro kinase assays were essentially performed as described previously (Lin et al., 2000) . In brief, GFP-aPKC was immunoprecipitated from lysates of transfected S2 cells as described above. The beads were washed once in washing buffer (150 mM NaCl and 50 mM Tris-HCl pH 7.5) and twice in reaction buffer (20 mM Hepes, pH 7.5, 5 mM MgCl, 1 mM dithiothreitol). Immunoprecipitates were incubated for 1 hour at 30°C in reaction buffer containing 2 g affinity purified GST-Baz, 250 M ATP, 0.3 Ci [-32 P]ATP, 0.1 mM cantharidin and protease inhibitors. The reaction was terminated by addition of SDS sample buffer and samples were subjected to SDS-PAGE. Phosphorylation was detected with PhosphorImager and quantified with Aida 2D Densitometry software. For non-radioactive kinase assays, phosphorylation of GST-Baz was determined by western blotting with the anti-BazpS980 phosphospecific antibody.
Generation of aPKC and Baz expression constructs
Details will be provided upon request.
Molecular dynamics simulations
ATP-binding free energy double differences (G Mut. f -G Mut. +ATP )-(G WT f -G WT +ATP ) and folding free energy differences (G Mut. u -G Mut. f )-(G WT u -G WT f ) have been calculated from the thermodynamic cycle shown in Fig. 6B via the mutation free energy differences G Mut.
f -G WT f , G Mut. u -G WT u and G Mut. +ATP -G WT +ATP in the folded, unfolded, and ATP-bound states, respectively. As models for the unfolded state, appropriately equilibrated tri-and penta-peptides were used with neutralized termini.
In all simulations, a cut-off of 1.07 nm for short-range Coulomb as well as Lennard-Jones forces was used. Particle-Mesh-Ewald with a grid spacing of 0.128 nm and an interpolation order of 4 was used for the long range electrostatics (Darden et al., 1993) . A 300 K, 1 bar NpT ensemble using Parinello-Rahman pressure ( p 5 picoseconds) (Parrinello and Rahman, 1981; Nosé and Klein, 1983) , V-rescale temperature coupling ( T 0.5 picoseconds) (Bussi et al., 2007) , and a 2-femtosecond time step with the LINCS algorithm (Hess et al., 1997) was used. All simulations were carried out with the TIP3P water model (Jorgensen et al., 1983 ) and a 150 mM NaCl concentration. All simulations were carried out with the GROMACS software package (version 4) (Hess et al., 2008) using the AMBER99SB force field (Hornak et al., 2006) for the protein and the parameters for ATP and ions from Meagher et al. (Meagher et al., 2003) and Dang (Dang, 1995) . All free energy calculations were carried out with the Crooks' Gaussian Intersection (CGI) scheme (Goette and Grubmüller, 2009 ) and a soft-core potential (Beutler et al., 1994) for all Lennard-Jones interconversions, with 0.25. Fifty subsequent 50-picosecond thermodynamic integration simulations were carried out for each of the three mutations, and the obtained free energy differences and error estimates were calculated as described by Goette and Grubmüller (Goette and Grubmüller, 2009) .
Starting from the crystal structure of the catalytic domain of human protein kinase C (chain A of PDB entry 1ZRZ (Messerschmidt et al., 2005) ), with missing amino acids added (Fig. 6A) , the system was equilibrated for 200 nanoseconds. Three point mutations, A272V, G328N and F404I, were constructed using WHATIF (Vriend, 1990) with subsequent energy minimization and 100 nanosecond equilibration. After the equilibration of the apo-enzyme structures, Mg 2+ -ATP was inserted, and the systems were further equilibrated for 50 nanoseconds.
The small missing loop element (446-455) was implemented via tconcoord (Seeliger et al., 2007; Seeliger and De Groot, 2008) . Amino acids 532-555 were taken from the homologous structure 2I0E (Grodsky et al., 2006 ) (sequence identity 49%) with the respective amino acids mutated/inserted with WHATIF (Vriend, 1990) . The resulting structure was then solvated, energy minimized, and slowly heated up from 20 K to 300 K while position restraining all non-modeled atoms. To enhance sampling, the system was then simulated for 1 nanosecond at 500 K with identical position restraints. From this trajectory, ten snapshots were used for simulated annealing simulations where the temperature was reduced from 500 K to 300 K within 1 nanosecond. A suitable starting structure for the subsequent production runs was obtained via principal component analysis (supplementary material Fig. S5 ). The Mg 2+ -ATP complex structure was modeled from the equilibrated ligand-free protein by root mean square fitting using the binding pocket of the Mg-GMPPNP-containing homologous structure 1DAY (Niefind et al., 1999) . Stability of all simulations was monitored using the root mean square deviations (supplementary material Fig. S6 ).
